Lexicon Pharmaceuticals To Close Out Early Two Long-Term Outcome Studies Of Sotagliflozin Based On 'assessment that a near-term partnership sufficient to fund the studies to completion is now unlikely' As Well As Coronavirus Uncertainty
Benzinga Newsdesk